Essilor: Robust start to the year in terms of external growth (7 acquisitions this month!)

BUY, Fair Value EUR80 (+4%)

News published on January Thursday 31, 2013
Share on
Following the 5 operations announced last week, all located in emerging markets, Essilor announced this morning two new acquisitions in the US (cumulative sales of USD39m or c.EUR29m). Consequently, the world’s leading ophthalmic company is carrying out a dynamic external growth strategy as it has already finalised 7 acquisitions in January, for cumulative sales of c.EUR100m, implying a positive 2% scope effect.

Full report available to subscribers
Please contact

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities